# VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

> **NCT06409221** · — · ENROLLING_BY_INVITATION · sponsor: **Concr** · enrollment: 200 (estimated)

## Conditions studied

- Cancer, Breast
- Triple Negative Breast Cancer
- Early-stage Breast Cancer

## Interventions

- **OTHER:** Non-interventional study, Observational only

## Key facts

- **NCT ID:** NCT06409221
- **Lead sponsor:** Concr
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-05-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409221, "VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06409221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*